• Corpus ID: 1312175

Complications of HIV infection: a systems-based approach.

  title={Complications of HIV infection: a systems-based approach.},
  author={Carolyn Chu and Peter A Selwyn},
  journal={American family physician},
  volume={83 4},
  • C. ChuP. Selwyn
  • Published 15 February 2011
  • Medicine, Biology
  • American family physician
Patients with human immunodeficiency virus (HIV) infection often develop multiple complications and comorbidities. Opportunistic infections should always be considered in the evaluation of symptomatic patients with advanced HIV/AIDS, although the overall incidence of these infections has decreased. Primary care of HIV infection includes the early detection of some complications through screening at-risk and symptomatic patients with routine laboratory monitoring (e.g., comprehensive metabolic… 

HIV-Associated Complications: A Systems-Based Approach.

Family physicians who care for patients with HIV infection have a key role in identifying and managing many of these chronic complications, and new anti-hepatitis C agents produce high rates of sustained virologic response.

Initial Management of Patients with HIV Infection.

The scope of initial care, including obtaining a thorough history; physical examination for HIV-associated manifestations; attention to HIV- specific immunization schedules; routine and HIV-specific laboratory evaluation; and ensuring standard health care maintenance to prevent HIV- and non-HIV-related morbidity and mortality are described.

Primary care for children and adolescents living with HIV

Care of HIV-positive children and adolescents should have special emphasis on evaluation for possible cardiovascular and metabolic complications of HIV infection and its treatment, according to standard age-appropriate healthcare maintenance.

Microrna expression in patients with asymptomatic neurocognitive impairment and HIV associated dementia

There is a repeated increase in the expression of miRNA 134 and miRNA 3665 in patients with HIV dementia than in Patients with asymptomatic neurocognitive disorders and patients in the control group.

HIV and Noncommunicable Disease Comorbidities in the Era of Antiretroviral Therapy: A Vital Agenda for Research in Low- and Middle-Income Country Settings

Some of the challenges and opportunities for addressing HIV and NCD comorbidities in low- and middle-income countries are presented, and the research agenda that emerges from the articles that follow is previewed.

Risk Factor of Human Immunodeficiency virus Encephalopathy in Children

It was concluded that HIV prevalence in this study was 44%.

Opportunistic Infections in Aids Patients

Current knowledge on epidemiology, clinical features and treatment observed in these diseases are important in the management of patients with HIV and is the focus of this review.

HIV and aging: a clinical journey from Koch's postulate to the chronic disease model and the contribution of geriatric syndromes.

There is an urgent need for increased dialog between different disciplines, ensuring that the care of older HIV-positive individuals is guided by research that incorporates relevant functional outcome measures.

HIV/AIDS in Children: Current Update

Every pregnant woman should be tested for HIV to have a better chance of preventing transmission to her unborn child and there is no vaccine to prevent HIV and AIDS although researchers are working to develop one.



Complications of HIV disease and antiretroviral therapy.

  • J. CurrierD. Havlir
  • Medicine, Biology
    Topics in HIV medicine : a publication of the International AIDS Society, USA
  • 2005
New data presented on metabolic complications of HIV infection and antiretroviral therapy, including cardiovascular risk, lipid disorders and lipoatrophy, renal complications, hepatic complications, tuberculosis, and other bacterial infections are reviewed.

Complications of HIV disease and antiretroviral therapy.

There was continued emphasis on pathogenesis, management, and prevention of the long-term complications of HIV disease and its therapies, including cardiovascular disease, lipodystrophy, renal disease, and alterations in bone metabolism.

Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Only with greater awareness of kidney-disease manifestations and their implications in this particularly vulnerable population will the authors be able to achieve success in confronting this growing problem.

Complications of HIV disease and antiretroviral treatment.

Important data on prevention and optimal treatment of common coinfections that occur in HIV-infected individuals, including tuberculosis, influenza, and viral hepatitis were highlighted at the 17th Conference on Retroviruses and Opportunistic Infections.

Metabolic complications of antiretroviral therapy.

  • D. Sweet
  • Medicine, Biology
    Topics in HIV medicine : a publication of the International AIDS Society, USA
  • 2005
This article summarizes a presentation by Donna E. Sweet, MD, on the metabolic complications of long-term antiretroviral therapy at the IAS-USA course in New York in March 2005.

Neurologic complications of HIV disease and their treatment.

Therapy-focused studies identified that resistance testing of cerebrospinal fluid-derived HIV may improve management of people with HIV-associated neurologic complications, and that poorly penetrating antiretroviral therapy is associated with persistent low-level HIV RNA in CSF.

Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

  • G. McComseyP. Tebas T. Brown
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2010
The point that HIV infection should be considered as a risk factor for bone disease is made and patients with fragility fractures, HIV-infected post-menopausal women, and all HIV- infected men ⩾50 years of age are recommended to be screened.

Gastrointestinal complications of HIV infection: changing priorities in the HAART era

It has now been some 25 years since the initial description of AIDS and intense investigation has better characterised HIV, resulting in the development of effective drug therapies to arrest disease progression and, especially in the developing world, the cost and complexities of these regimens.

Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study

HAART was associated with a substantial reduction in HIVAN incidence and additional follow-up will be needed to determine if renal damage in susceptible individuals is halted or merely slowed by HAART, particularly when control of viremia is incomplete or intermittent.

Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.

  • J. AbergJ. Kaplan J. Gallant
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2009
These updated guidelines replace those published in 2004 and are intended for use by health care providers who care for HIV-infected patients or patients who may be at risk for acquiring HIV infection.